1ACTIVITIES
1ORGS REPRESENTED
20BILLS
Organizations represented
1Orgs whose LD-2 filings list Julie as an active lobbyist, sorted by activity volume.
Bills they file on
20S. 3551 mention
S. 6521 mention
S. 8321 mention
S. 8641 mention
S. 8911 mention
S. 9321 mention
S. 14141 mention
S. 19541 mention
S. 22961 mention
S. 26581 mention
S. 27101 mention
S. 33451 mention
H.R. 9461 mention
H.R. 12621 mention
H.R. 14921 mention
+ 5 more bills referenced in their activities
Topics in Filings
33Policy topics Julie files on across all their LD-2 activities.
FDA Modernization×1
Bipartisan Health Care Act×1
Modernizing and Ensuring PBM Accountability×1
Biosimilar Red Tape Elimination Act×1
BIOSECURE Act×1
Show all 33 topics (+28 more) ▾
Open Payments Expansion Act×1
PBM Price Transparency and Accountability Act×1
One Big Beautiful Bill Act×1
Mikaela Naylon Give Kids a Chance Act×1
PBM Reform×1
HELP Copays Act×1
Accountability, and Integrity Now and for the Future×1
User fee issues×1
Vaccine policy×1
Inflation Reduction Act×1
IRA price negotiation expansion policy×1
Pharmacy Benefit Manager reform×1
Drug cost and pricing policy×1
Most Favored Nation×1
Drug importation policy×1
FDA policy×1
MAHA Commission Report×1
Make Our Children Healthy Again Competition policy×1
Orphan Drug Act×1
Antimicrobial resistance policy×1
Compounding policy×1
Supply chain policy×1
Clinical trial policy×1
Issues 340B drug discount program rebate and policy×1
Issues 340B rebate pilot program Patient assistance program policy×1
Biosimilar approval and reimbursement policy×1
Biosimilars Access and Affordability Act×1
Artificial intelligence policy×1
Pulled from the org’s own LD-2 disclosures. See the source filings ↓
Issue mix
LDA general-issue codes weighted by activity count.
Health Issues1